SLC10A2 and inflammatory bowel disease: In conclusion, this study demonstrated that uridine exerts potential therapeutic and anti-inflammatory effects on Inflammatory Bowel Disease (IBD) through the modulation of slc10a2. These findings not only deepen our understanding of IBD pathogenesis but also provide a novel therapeutic target for future IBD interventions.